LARIPENEM-500

bt_bb_section_bottom_section_coverage_image

Composition

A Potent Antibiotic for ESBL-Producing Organisms

Laripenem-500 is a combination antibiotic containing imipenem and cilastatin. It’s a valuable treatment option for infections caused by extended-spectrum beta-lactamase (ESBL)-producing organisms, which are bacteria that have developed resistance to many common antibiotics.

Key Features of Laripenem-500

  • Imipenem: A powerful carbapenem antibiotic with a broad spectrum of activity against both gram-positive and gram-negative bacteria, including ESBL-producing organisms.
  • Cilastatin: A beta-lactamase inhibitor that protects imipenem from breakdown in the kidneys, enhancing its effectiveness.
  • Strong Clinical Results: Laripenem-500 has shown excellent clinical results in treating severe infections, especially in intensive care units.

Indications for Laripenem-500

  • Bone and Joint Infections: Osteomyelitis, arthritis
  • Lower Respiratory Tract Infections (LRTIs): Pneumonia
  • Intra-abdominal Infections: Peritonitis, abscesses
  • Skin and Soft Tissue Infections: Cellulitis, abscesses
  • Urinary Tract Infections: Cystitis, pyelonephritis
  • Gynecological Infections: Pelvic inflammatory disease, endometritis

Dosage:

The typical dosage of Laripenem-500 is 1-2 grams per day, divided into doses every 6-8 hours. However, the specific dosage may vary depending on the severity of the infection, the patient’s weight, and renal function.

Note: Always consult with a healthcare professional for personalized dosing instructions.

Importance of Carbapenems for ESBL-Producing Organisms

Carbapenems like imipenem are often considered the last line of defense against ESBL-producing organisms. These bacteria are resistant to many other antibiotics, making infections caused by them difficult to treat. Using carbapenems judiciously can help preserve their effectiveness for future use.

Remember: While Laripenem-500 is a powerful antibiotic, it’s essential to use it appropriately under the guidance of a healthcare professional to prevent the development of antibiotic resistance.

Disclaimer: This information is for general knowledge only and should not be considered medical advice. Always consult with a healthcare professional for personalized guidance.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2024/05/LARIPENEM-500.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved